Brief: Hemogenyx Pharmaceuticals' HG-CT-1 Treatment Passes Initial Safety Assessment
24/03/2025 07:37
March 24 (Reuters) - Hemogenyx Pharmaceuticals PLC HEMO.L: HEMOGENYX PHARMACEUTICALS PLC - HG-CT-1 TREATMENT PASSES INITIAL SAFETY ASSESSMENT Source text: ID:nRSX8348Ba Further company coverage: HEMO.L ((Reuters.Briefs@thomsonreuters.com;))